| - GRCh37:
- Chr17:7571520-7571521
- GRCh38:
- Chr17:7668202-7668203
| TP53 | | Li-Fraumeni syndrome | Pathogenic (May 18, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7571720-7573008
- GRCh38:
- Chr17:7668402-7669690
| TP53 | | Li-Fraumeni syndrome | Likely pathogenic (Jun 4, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572906-7579931
- GRCh38:
- Chr17:7669588-7676613
| TP53 | M1fs | B-cell chronic lymphocytic leukemia | Pathogenic (Mar 19, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr17:7572917-7579922
- GRCh38:
- Chr17:7669599-7676604
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Jan 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572921-7579918
- GRCh38:
- Chr17:7669603-7676600
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Aug 14, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572921-7574039
- GRCh38:
- Chr17:7669603-7670721
| TP53 | | Li-Fraumeni syndrome | Likely pathogenic (Feb 15, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7572984
- GRCh38:
- Chr17:7669666
| TP53 | Q243fs, Q216fs, Q375fs, Q336fs | not provided | Pathogenic (Mar 23, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573009
- GRCh38:
- Chr17:7669691
| TP53 | | Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
| Pathogenic/Likely pathogenic (Jul 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7573010
- GRCh38:
- Chr17:7669692
| TP53 | | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome | Pathogenic/Likely pathogenic (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7573925
- GRCh38:
- Chr17:7670607
| TP53 | | Li-Fraumeni syndrome | Likely pathogenic (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573944
- GRCh38:
- Chr17:7670626
| TP53 | S323fs, S362fs, S230fs, S203fs | Bone marrow failure syndrome 5 | Pathogenic (Jan 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573950
- GRCh38:
- Chr17:7670632
| TP53 | S323fs, S362fs, S203fs, S230fs | Bone marrow failure syndrome 5 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573967
- GRCh38:
- Chr17:7670649
| TP53 | Q354*, Q222*, Q315*, Q195* | Li-Fraumeni syndrome | Likely pathogenic (Aug 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573972-7573981
- GRCh38:
- Chr17:7670654-7670663
| TP53 | E190fs, E217fs, E310fs, E349fs | Li-Fraumeni syndrome | Likely pathogenic (Aug 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573973
- GRCh38:
- Chr17:7670655
| TP53 | D220fs, D313fs, D352fs, D193fs | Li-Fraumeni syndrome | Likely pathogenic (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573975
- GRCh38:
- Chr17:7670657
| TP53 | K192fs, K219fs, K312fs, K351fs | Li-Fraumeni syndrome | Likely pathogenic (Aug 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573976
- GRCh38:
- Chr17:7670658
| TP53 | K192*, K219*, K312*, K351* | Lung adenocarcinoma | Pathogenic (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573976-7573984
- GRCh38:
- Chr17:7670658-7670666
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Feb 4, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573977-7573978
- GRCh38:
- Chr17:7670659-7670660
| TP53 | L191fs, L311fs, L350fs, L218fs | Hereditary cancer-predisposing syndrome | Pathogenic (Feb 21, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573982
- GRCh38:
- Chr17:7670664
| TP53 | E217*, E310*, E349*, E190* | Li-Fraumeni syndrome, not provided | Pathogenic (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7573984
- GRCh38:
- Chr17:7670666
| TP53 | L189fs, L216fs, L309fs, L348fs | Li-Fraumeni syndrome | Likely pathogenic (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573987
- GRCh38:
- Chr17:7670669
| TP53 | A215D, A308D, A347D, A188D | Li-Fraumeni syndrome | Likely pathogenic (Mar 18, 2022) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7573991
- GRCh38:
- Chr17:7670673
| TP53 | E214*, E307*, E346*, E187* | Li-Fraumeni syndrome | Pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7573991
- GRCh38:
- Chr17:7670673
| TP53 | E187fs, E346fs, E214fs, E307fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7573993-7574000
- GRCh38:
- Chr17:7670675-7670682
| TP53 | | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7573996
- GRCh38:
- Chr17:7670678
| TP53 | L344P, L212P, L305P, L185P | Li-Fraumeni syndrome | Likely pathogenic (Aug 28, 2019) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7573999
- GRCh38:
- Chr17:7670681
| TP53 | E184fs, E211fs, E304fs, E343fs | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Pathogenic/Likely pathogenic (Jun 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7573999-7574008
- GRCh38:
- Chr17:7670681-7670690
| TP53 | M340fs, M181fs, M208fs, M301fs | Hereditary cancer-predisposing syndrome | Pathogenic (May 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7574002
- GRCh38:
- Chr17:7670684
| TP53 | R210P, R303P, R342P, R183P | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome | Pathogenic/Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574003
- GRCh38:
- Chr17:7670685
| TP53 | R183fs, R303fs, R342fs, R210fs | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574003
- GRCh38:
- Chr17:7670685
| TP53 | R210*, R303*, R342*, R183* | Glioma susceptibility 1, Li-Fraumeni syndrome 1, Basal cell carcinoma, susceptibility to, 7, Adrenocortical carcinoma, hereditary, Bone osteosarcoma, Nasopharyngeal carcinoma, Carcinoma of pancreas, Hepatocellular carcinoma, Familial cancer of breast, Colorectal cancer, Choroid plexus papillomaBone marrow failure syndrome 5, Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, ...see more | Pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574006
- GRCh38:
- Chr17:7670688
| TP53 | F209fs, F341fs, F182fs, F302fs | Li-Fraumeni syndrome | Pathogenic (Nov 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7574009
- GRCh38:
- Chr17:7670691
| TP53 | M340fs, M181fs, M208fs, M301fs | Hereditary cancer-predisposing syndrome | Pathogenic (Jun 8, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7574012-7574013
- GRCh38:
- Chr17:7670694-7670695
| TP53 | E180fs, E207fs, E300fs, E339fs | Li-Fraumeni syndrome | Pathogenic (Oct 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7574012-7574013
- GRCh38:
- Chr17:7670694-7670695
| TP53 | E207*, E180*, E300*, E339* | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7574012
- GRCh38:
- Chr17:7670694
| TP53 | E207*, E300*, E339*, E180* | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574016-7574017
- GRCh38:
- Chr17:7670698-7670699
| TP53 | R298fs, R178fs, R205fs, R337fs | Hereditary cancer-predisposing syndrome | Pathogenic (Jul 25, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7574017
- GRCh38:
- Chr17:7670699
| TP53 | R205P, R298P, R337P, R178P | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574017
- GRCh38:
- Chr17:7670699
| TP53 | R205L, R298L, R337L, R178L | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Familial cancer of breast
| Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574017
- GRCh38:
- Chr17:7670699
| TP53 | R337H, R205H, R298H, R178H | Glioma susceptibility 1, Adrenocortical carcinoma, hereditary, Nasopharyngeal carcinoma, Bone osteosarcoma, Colorectal cancer, Familial cancer of breast, Bone marrow failure syndrome 5, Hepatocellular carcinoma, Basal cell carcinoma, susceptibility to, 7, Carcinoma of pancreas, Choroid plexus papillomaLi-Fraumeni syndrome 1, Breast neoplasm, Hereditary cancer-predisposing syndrome, not provided, Hereditary breast ovarian cancer syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Squamous cell carcinoma of the head and neck, See cases, ...see more | Pathogenic/Likely pathogenic (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574018
- GRCh38:
- Chr17:7670700
| TP53 | R205C, R298C, R337C, R178C | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome | Pathogenic/Likely pathogenic (Feb 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574024-7574055
- GRCh38:
- Chr17:7670706-7670737
| TP53 | | Neoplasm of ovary | Likely pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7574027
- GRCh38:
- Chr17:7670709
| TP53 | G202W, G295W, G334W, G175W | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 | Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574030
- GRCh38:
- Chr17:7670712
| TP53 | R201fs, R294fs, R333fs, R174fs | Li-Fraumeni syndrome | Pathogenic (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7574030-7574031
- GRCh38:
- Chr17:7670712-7670713
| TP53 | I293fs, I173fs, I200fs, I332fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7574032
- GRCh38:
- Chr17:7670714
| TP53 | I173N, I200N, I293N, I332N | Hereditary cancer-predisposing syndrome | Likely pathogenic (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7574034
- GRCh38:
- Chr17:7670716
| TP53 | | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574034
- GRCh38:
- Chr17:7670716
| TP53 | | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 | Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7574035
- GRCh38:
- Chr17:7670717
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Pathogenic (Jul 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576851
- GRCh38:
- Chr17:7673533
| TP53 | | Familial cancer of breast, Hereditary cancer-predisposing syndrome | Likely pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576852
- GRCh38:
- Chr17:7673534
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576852
- GRCh38:
- Chr17:7673534
| TP53 | | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 | Pathogenic/Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576852
- GRCh38:
- Chr17:7673534
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Aug 28, 2019) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7576852
- GRCh38:
- Chr17:7673534
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, not provided, Li-Fraumeni syndrome 1 | Pathogenic/Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576853-7576854
- GRCh38:
- Chr17:7673535-7673536
| TP53 | D173fs, D200fs, D293fs, D332fs, I173fs, I200fs, I293fs, I332fs, M173fs, M200fs, M293fs, M332fs | Li-Fraumeni syndrome | Likely pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576853-7576856
- GRCh38:
- Chr17:7673535-7673538
| TP53 | Q331fs, Q199fs, Q172fs, Q292fs | Li-Fraumeni syndrome | Pathogenic (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576853
- GRCh38:
- Chr17:7673535
| TP53 | | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, not provided | Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576855
- GRCh38:
- Chr17:7673537
| TP53 | Q199*, Q331*, Q292*, Q172* | Hereditary cancer-predisposing syndrome | Pathogenic (Mar 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576856
- GRCh38:
- Chr17:7673538
| TP53 | Q172fs, Q199fs, Q331fs, Q292fs | Li-Fraumeni syndrome | Pathogenic (Jan 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576858
- GRCh38:
- Chr17:7673540
| TP53 | L198fs, L291fs, L330fs, L171fs | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome | Pathogenic (Dec 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576860-7576878
- GRCh38:
- Chr17:7673542-7673560
| TP53 | L323fs, L164fs, L191fs, L284fs | Hereditary cancer-predisposing syndrome | Pathogenic (May 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576862-7576863
- GRCh38:
- Chr17:7673544-7673545
| TP53 | T197fs, T170fs, T290fs, T329fs | Li-Fraumeni syndrome | Pathogenic (Apr 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576862-7576863
- GRCh38:
- Chr17:7673544-7673545
| TP53 | T290fs, T329fs, T197fs, T170fs | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome | Pathogenic (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576865
- GRCh38:
- Chr17:7673547
| TP53 | Y168*, Y195*, Y327*, Y288* | Li-Fraumeni syndrome | Pathogenic (May 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576865-7576866
- GRCh38:
- Chr17:7673547-7673548
| TP53 | Y168fs, Y195fs, Y327fs, Y288fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7576865
- GRCh38:
- Chr17:7673547
| TP53 | Y195*, Y288*, Y327*, Y168* | not provided | Likely pathogenic (Aug 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576868-7576869
- GRCh38:
- Chr17:7673550-7673551
| TP53 | Y168fs, Y288fs, Y327fs, Y195fs | Hereditary cancer-predisposing syndrome | Pathogenic (Jul 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576870
- GRCh38:
- Chr17:7673552
| TP53 | E194*, E287*, E326*, E167* | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576873
- GRCh38:
- Chr17:7673555
| TP53 | G193*, G286*, G325*, G166* | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, not provided
| Pathogenic (Apr 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576876
- GRCh38:
- Chr17:7673558
| TP53 | D165fs, D192fs, D285fs, D324fs | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr17:7576881
- GRCh38:
- Chr17:7673563
| TP53 | P190fs, P163fs, P283fs, P322fs | Hereditary cancer-predisposing syndrome | Pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576885
- GRCh38:
- Chr17:7673567
| TP53 | K189*, K282*, K162*, K321* | Li-Fraumeni syndrome | Pathogenic (May 25, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576888
- GRCh38:
- Chr17:7673570
| TP53 | K161*, K188*, K281*, K320* | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome | Pathogenic (Dec 16, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576892-7576895
- GRCh38:
- Chr17:7673574-7673577
| TP53 | P159fs, P186fs, P279fs, P318fs | Hereditary cancer-predisposing syndrome | Pathogenic (Nov 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576896
- GRCh38:
- Chr17:7673578
| TP53 | Q158fs, Q317fs, Q185fs, Q278fs | Hereditary cancer-predisposing syndrome | Pathogenic (Jul 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576897
- GRCh38:
- Chr17:7673579
| TP53 | Q185fs, Q278fs, Q158fs, Q317fs | Li-Fraumeni syndrome | Pathogenic (Jan 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576897
- GRCh38:
- Chr17:7673579
| TP53 | Q185*, Q278*, Q317*, Q158* | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1 | Pathogenic/Likely pathogenic (Mar 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576900-7576901
- GRCh38:
- Chr17:7673582-7673583
| TP53 | P157fs, P316fs, P184fs, P277fs | Li-Fraumeni syndrome | Pathogenic (Feb 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576900-7576901
- GRCh38:
- Chr17:7673582-7673583
| TP53 | Q278fs, Q185fs, Q317fs, Q158fs | Li-Fraumeni syndrome | Pathogenic (Dec 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576900-7576909
- GRCh38:
- Chr17:7673582-7673591
| TP53 | S181fs, S274fs, S154fs, S313fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7576901
- GRCh38:
- Chr17:7673583
| TP53 | Q158fs, Q185fs, Q278fs, Q317fs | Li-Fraumeni syndrome | Pathogenic (Oct 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576913-7576914
- GRCh38:
- Chr17:7673595-7673596
| TP53 | N311fs, N179fs, N152fs, N272fs | Hereditary cancer-predisposing syndrome | Pathogenic (Mar 20, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576913
- GRCh38:
- Chr17:7673595
| TP53 | N179fs, N311fs, N152fs, N272fs | Neoplasm of ovary | Pathogenic (Dec 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr17:7576919
- GRCh38:
- Chr17:7673601
| TP53 | N178fs, N310fs, N271fs, N151fs | not provided | Pathogenic (May 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576923-7576929
- GRCh38:
- Chr17:7673605-7673611
| TP53 | | Li-Fraumeni syndrome | Likely pathogenic (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576926-7576930
- GRCh38:
- Chr17:7673608-7673612
| TP53 | | Li-Fraumeni syndrome | Likely pathogenic (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576927
- GRCh38:
- Chr17:7673609
| TP53 | | Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576927
- GRCh38:
- Chr17:7673609
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Oct 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7576927
- GRCh38:
- Chr17:7673609
| TP53 | | Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome | Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7576928
- GRCh38:
- Chr17:7673610
| TP53 | | Breast and/or ovarian cancer, Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 | Pathogenic/Likely pathogenic (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577004-7577021
- GRCh38:
- Chr17:7673686-7673703
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577009-7577021
- GRCh38:
- Chr17:7673691-7673703
| TP53 | | Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome | Pathogenic/Likely pathogenic (Aug 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577013-7577021
- GRCh38:
- Chr17:7673695-7673703
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577017
- GRCh38:
- Chr17:7673699
| TP53 | | Hereditary breast ovarian cancer syndrome | Pathogenic (May 21, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577017
- GRCh38:
- Chr17:7673699
| TP53 | | Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
| Pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577018
- GRCh38:
- Chr17:7673700
| TP53 | | Li-Fraumeni syndrome | Pathogenic (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:7577018-7577019
- GRCh38:
- Chr17:7673700-7673701
| TP53 | | Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
| Pathogenic/Likely pathogenic (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:7577018
- GRCh38:
- Chr17:7673700
| TP53 | | Li-Fraumeni syndrome | Likely pathogenic (Aug 28, 2019) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:7577018
- GRCh38:
- Chr17:7673700
| TP53 | | Colorectal cancer | Likely pathogenic (Jul 11, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr17:7577018
- GRCh38:
- Chr17:7673700
| TP53 | | Hereditary cancer-predisposing syndrome | Likely pathogenic (Apr 11, 2016) | criteria provided, single submitter |